CellaVision AB (CEVI) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.058x

Based on the latest financial reports, CellaVision AB (CEVI) has a cash flow conversion efficiency ratio of 0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.43 Million ≈ $5.53 Million USD) by net assets (Skr887.58 Million ≈ $95.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CEVI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

CellaVision AB - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how CellaVision AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CellaVision AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CellaVision AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MGP Ingredients Inc NASDAQ:MGPI	0.041x
Enento Group Plc HE:ENENTO	0.057x
Ngx Energy International Corp V:GASX	-0.013x
Guangdong Anjubao Digital Tech SHE:300155	0.000x
VRG SA WAR:VRG	0.016x
ZheJiang HuaSheng Technology Co.Ltd SHG:605180	N/A
M-tron Industries, Inc. NYSE MKT:MPTI	0.042x
Royal Group Co Ltd SHE:002329	0.068x

Annual Cash Flow Conversion Efficiency for CellaVision AB (2006–2025)

The table below shows the annual cash flow conversion efficiency of CellaVision AB from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of CellaVision AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr887.58 Million ≈ $95.52 Million	Skr200.53 Million ≈ $21.58 Million	0.226x	-7.13%
2024-12-31	Skr815.73 Million ≈ $87.79 Million	Skr198.44 Million ≈ $21.36 Million	0.243x	-11.28%
2023-12-31	Skr716.39 Million ≈ $77.09 Million	Skr196.44 Million ≈ $21.14 Million	0.274x	+28.15%
2022-12-31	Skr641.63 Million ≈ $69.05 Million	Skr137.28 Million ≈ $14.77 Million	0.214x	-27.22%
2021-12-31	Skr543.28 Million ≈ $58.47 Million	Skr159.72 Million ≈ $17.19 Million	0.294x	+77.58%
2020-12-31	Skr429.62 Million ≈ $46.23 Million	Skr71.12 Million ≈ $7.65 Million	0.166x	-54.22%
2019-12-31	Skr348.37 Million ≈ $37.49 Million	Skr125.99 Million ≈ $13.56 Million	0.362x	+41.78%
2018-12-31	Skr290.38 Million ≈ $31.25 Million	Skr74.07 Million ≈ $7.97 Million	0.255x	-30.10%
2017-12-31	Skr240.85 Million ≈ $25.92 Million	Skr87.90 Million ≈ $9.46 Million	0.365x	-1.73%
2016-12-31	Skr206.18 Million ≈ $22.19 Million	Skr76.57 Million ≈ $8.24 Million	0.371x	-22.55%
2015-12-31	Skr183.52 Million ≈ $19.75 Million	Skr88.00 Million ≈ $9.47 Million	0.480x	+82.35%
2014-12-31	Skr151.30 Million ≈ $16.28 Million	Skr39.78 Million ≈ $4.28 Million	0.263x	+27.77%
2013-12-31	Skr132.52 Million ≈ $14.26 Million	Skr27.27 Million ≈ $2.93 Million	0.206x	+123.68%
2012-12-31	Skr124.91 Million ≈ $13.44 Million	Skr11.49 Million ≈ $1.24 Million	0.092x	-63.77%
2011-12-31	Skr126.07 Million ≈ $13.57 Million	Skr32.02 Million ≈ $3.45 Million	0.254x	+151.39%
2010-12-31	Skr113.42 Million ≈ $12.21 Million	Skr11.46 Million ≈ $1.23 Million	0.101x	-63.28%
2009-12-31	Skr74.80 Million ≈ $8.05 Million	Skr20.58 Million ≈ $2.21 Million	0.275x	+896.24%
2008-12-31	Skr45.98 Million ≈ $4.95 Million	Skr1.27 Million ≈ $136.67K	0.028x	-91.68%
2007-12-31	Skr20.07 Million ≈ $2.16 Million	Skr6.67 Million ≈ $717.37K	0.332x	+519.92%
2006-12-31	Skr17.73 Million ≈ $1.91 Million	Skr950.00K ≈ $102.24K	0.054x	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$351.14 Million

Skr3.26 Billion SEK

Market Cap Rank

#14179 Global

#222 in Sweden

Share Price

Skr136.80

Change (1 day)

-3.12%

52-Week Range

Skr118.40 - Skr189.40

All Time High

Skr478.48